Approximately 1.1 percent of men and women will be diagnosed with differentiated thyroid cancer at some point during their lifetime, based on 2008-2010 SEER data.
In 2011, it’s estimated that there were 566,708 people living with thyroid cancer in the United States and thyroid cancer represents 3.8% of all new cancer cases.
Additionally, recent studies demonstrate that thyroid cancer rates seem to be rising.
The 5 year survival rate from differentiated thyroid cancer is estimated between 97 and 99%, although some less common forms of thyroid cancer have lower survival rates.
Among the most well-established risk factors include:
Other risk factors include:
Nuclear scan or radioactive iodine uptake (RAI0U) scan. Nodules that absorb more radioactive iodine are known as hot nodules and are more likely benign.
CT scan which is a type of X-ray that can diagnose larger thyroid nodules or goiter.
MRI can locate tumors, assess tumor size and look for tumor spread.
Thyroid ultrasound can detect a thyroid nodule in a fluid filled cyst or if it is a solid filled mass. However a needle biopsy will need to be done to determine the type of tissue found in the nodule.
Needle Biopsy Suspicious thyroid nodules will need to be biopsied. Typically thyroid nodules are biopsied using a needle, in a procedure known as fine needle aspiration biopsy.
Multiple nutritional supplements have been associated with reduced cancer incidence and/or cancer progression. The list below contains those with the greatest evidence-base and benefit, though it is not necessary that they all be included.
 Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22.
 Horn-Ross PL, Lichtensztajn DY, Clarke CA, Dosiou C, Oakley-Girvan I, Reynolds P, Gomez SL, Nelson DO. Continued rapid increase in thyroid cancer incidence in california: trends by patient, tumor, and neighborhood characteristics. Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1067-79.
 Davies L, Welch HG. Thyroid cancer survival in the United States: observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg. 2010 May;136(5):440-4.
 Sadetzki S, Chetrit A, Lubina A, Stovall M, Novikov I. Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis. J Clin Endocrinol Metab. 2006 Dec;91(12):4798-804. Epub 2006 Oct 3.
 Gramatges MM, Liu Q, Yasui Y, Okcu MF, Neglia JP, Strong LC, Armstrong GT, Robison LL, Bhatia S. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Clin Cancer Res. 2014 Feb 15;20(4):904-11.
 Yang YM, Zhang TT, Yuan L, Ren Y. The association between the C677T polymorphism in MTHFR gene and the risk of thyroid cancer: a meta-analysis. Eur Rev Med Pharmacol Sci. 2014 Aug;18(15):2097-101.
 Brehar AC, Brehar FM, Bulgar AC, Dumitrache C. Genetic and epigenetic alterations in differentiated thyroid carcinoma. J Med Life. 2013 Dec 15;6(4):403-8. Epub 2013 Dec 25.
 Derwahl M, Nicula D. Estrogen and its role on thyroid cancer. Endocr Relat Cancer. 2014 Jul 22. pii: ERC-14-0053.
 Kim SH, Park HS, Kim KH, Yoo H, Chae BJ, Bae JS, Jung SS, Song BJ. Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer. Surg Today. 2014 Jul 25.
 Xu L, Port M, Landi S, Gemignani F, Cipollini M, Elisei R, Goudeva L, Müller JA, Nerlich K, Pellegrini G, Reiners C, Romei C, Schwab R, Abend M, Sturgis EM. Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies. Thyroid. 2014 Jun;24(6):966-74.
 Yeo Y, Ma SH, Hwang Y, Horn-Ross PL, Hsing A, Lee KE, Park YJ, Park DJ, Yoo KY, Park SK. Diabetes mellitus and risk of thyroid cancer: a meta-analysis. PLoS One. 2014 Jun 13;9(6):e98135.
 Mack WJ, Preston-Martin S, Bernstein L, Qian D. Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol. 2002 Aug;12(6):395-401.